Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2005
12/29/2005WO2005123753A1 2-amino- and 2-hydroxy-2-phosphino-alkanic-acid derivatives and 2-phosphoniobis(2-hydroxy-alkanic-acid)-derivatives, method for the production of said derivatives and use of said derivatives in the production of metal catalysts
12/29/2005WO2005123752A1 Metal complexes of 2-amino- and 2-hydroxy-2-phosphino alkanic acid derivatives, method for the production of said metal complexes and use thereof as catalysts for the oligomerization or polymerization of olefins
12/29/2005WO2005123729A1 Lewis acid mediated synthesis of cyclic esters
12/29/2005WO2005123652A1 Rare earth metal complex light-emitting material having aromatic organic ligand
12/29/2005WO2005123642A1 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
12/29/2005WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
12/29/2005WO2005122891A1 Lipophilic derivatives of chelate monoamides
12/29/2005WO2005105780A3 Compositions useful as inhibitors of rock and other protein kinases
12/29/2005US20050288531 Phosphine compounds, transition metal complexes with the compounds contained as ligands therein, and asymmetric synthesis catalysts containing the complexes
12/29/2005US20050288523 Chiral diphosphorus compounds and transition metal complexes thereof
12/29/2005US20050288509 Preparation of biphosphonic acids and salts thereof
12/29/2005US20050288505 Metal complexes for catalytic carbon-carbon bond formation
12/29/2005US20050288504 Ligands for metals as catalysts for carbon-carbon bond formation
12/29/2005US20050288269 Analogs of benzoquinone-containing ansamycins and methods of use thereof
12/29/2005US20050288258 Compounds, compositions and methods for treating or preventing viral infections and associated diseases
12/29/2005US20050288240 Conversion by human liver microsomes to MPO3H2; hepatitis, cancer, liver fibrosis, malaria, other viral and parasitic infections, and metabolic diseases where the liver is responsible for the overproduction of the biochemical end product, diabetes; enhanced oral drug delivery
12/29/2005US20050287076 Compounds for use as surfactants
12/29/2005US20050287074 Matrix metalloproteinase inhibitors
12/29/2005DE112004000207T5 Organische Arsonsäureverbindungen Organic Arsonsäureverbindungen
12/29/2005DE102004026799A1 Pressgranulierte Flammschutzmittelzusammensetzung The compression-granulated flame retardant composition
12/29/2005CA2569461A1 Lipophilic derivatives of chelate monoamides
12/29/2005CA2565966A1 Lewis acid mediated synthesis of cyclic esters
12/28/2005EP1610126A1 A system for determining the electrical potential across a membrane
12/28/2005EP1609795A1 Process for the preparation of asymmetrically substituted biaryldiphosphines
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1609504A1 T-type calcium channel blockers
12/28/2005EP1608704A2 Thiophosphine compounds and method of making polymerisable compositions containing them and their use for making ophtalmic lenses
12/28/2005EP1608668A2 Tertiary phosphines and their methods of preparation
12/28/2005EP1608667A1 Phosphonium salts and methods of their preparation
12/28/2005EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
12/28/2005EP1377593B1 2-amino-propanol derivatives
12/28/2005EP1265831B1 Separation of reaction products containing organophosphorus complexes
12/28/2005EP1161418B1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
12/28/2005EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
12/28/2005CN1714096A Mmp inhibitors
12/28/2005CN1714095A Cardiolipin molecules and method of synthesis
12/28/2005CN1714094A Cardiolipin compositions their methods of preparation and use
12/28/2005CN1712406A Vanadium phosphate compound with hole-channel structure and synthesis thereof
12/28/2005CN1233647C Preparation of VC-2 phosphate ester salt
12/27/2005CA2356325C Topical compositions comprising protected functional thiols
12/27/2005CA2242530C Benzimidazole phosphono-amino acids
12/27/2005CA2160712C Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
12/22/2005WO2005121220A2 Preparation of polyphosphonates via transesterification without a catalyst
12/22/2005WO2005121157A1 Monophosphine compounds, transition metal complexes thereof and production of optically active compounds using the complexes as asymmetric catalysts
12/22/2005WO2005121086A2 Piperidinyl prostaglandin analogs as ocular hypotensive agents
12/22/2005WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005WO2005002007A3 Process for producing semiconductor nanocrystal cores, core-shell, core-buffer-shell, and multiple layer systems in a non-coordinating solvent utilizing in situ surfactant generation
12/22/2005WO2005001030A3 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
12/22/2005US20050283027 Dehalogenation of a dihalo(organyl)phosphane with activated zinc in an organic solvent, or with sodium in a non-polar organic solvent in the presence of tetramethylethylenediamine
12/22/2005US20050282982 Amido complexes of vanadium for olefin polymerization
12/22/2005US20050282839 Pyrimidyl phosphonate antiviral compounds and methods of use
12/22/2005US20050282783 Obtained by reacting sodium zoledronate with calcium orthophosphates in water, bone remodeling equilibrium; the local treatment of a bone problem on the main at-risk sites identified (neck of the femur )
12/22/2005US20050282782 Lewis acid mediated synthesis of cyclic esters
12/22/2005DE102004063360A1 New bisphenyl-2,3,5,6-tetrafluoro-4-trifluoromethylphenylphosphine oxide compound for use as monomer for preparing polyimide useful as material for e.g. electronic products, molding products, heat-resistant adhesives, and insulation
12/22/2005DE102004027332A1 New organometallic transition metal compound useful as catalyst constituents of catalyst systems for the polymerization of ethylene
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/21/2005EP1607401A1 Novel aryl fructose-1,6-Bisphosphatase inhibitors
12/21/2005EP1607400A2 Salts of dialkylphosphinic acids, process for their preparation and their use
12/21/2005EP1607399A2 BIS-(N,N'-BIS-(2-Haloethyl)Amino) Phosphoramidates as antitumor agents
12/21/2005EP1607398A1 Process for reduced crude sediment in metal salts of hydrocarbyl dithiophosphoric acid
12/21/2005EP1607397A1 Vanadium-amido complexes for olefin polymerization
12/21/2005EP1607004A1 Food composition suitable for shallow frying comprising sunflower lecithin
12/21/2005EP1607003A1 Food composition suitable for shallow frying comprising sunflower lecithin
12/21/2005EP1606295A1 Heteroaryl phosphonates, compositions containing them and methods of treatment of various disorders using them
12/21/2005EP1606294A1 Polymerisation catalysts
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1278759B1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
12/21/2005EP1153928B1 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes
12/21/2005CN1709920A Amido complexes of vanadium for olefin polymerization
12/21/2005CN1709898A Cyclic petroleum phosphate compound and its preparation
12/21/2005CN1709897A Synthesis of compound 9,10-dihydro-9-oxy-10-phospha phenanthrene and purification process thereof
12/21/2005CN1709896A Magnesium salt of creatine phosphate, its preparation and use in pharmaceutical process
12/21/2005CN1709895A Method for separating and purifying lecithinum
12/21/2005CN1709894A Method for synthesizing polypren phosphate
12/21/2005CN1232524C Insecticide diazinon preparation method
12/21/2005CN1232523C Method for producing dialkylphosphinic acids
12/20/2005US6977312 Phosphor, arsenic and antimony compounds based upon diaryl-anellated bicyclo[2.2.n] parent substances and catalysts containing same
12/20/2005US6977303 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
12/20/2005US6977302 useful in treatment of fungal infections in humans and other mammals
12/20/2005CA2118461C Process for the production of dialkyl pyrimidylphosphates
12/15/2005WO2005118654A1 Transition metal compound, ligand system, catalyst system and process for preparing polyolefins
12/15/2005WO2005118618A1 Substituted propane phosphinic acid derivatives
12/15/2005WO2005118606A1 Fluorine-substituted iridium complex and luminescent material made with the same
12/15/2005WO2005118604A1 Phosphorus-containing compounds useful for making halogen-free, ignition-resistant polymers
12/15/2005WO2005118603A1 Chiral phosphorus compounds
12/15/2005WO2005118602A1 1,1,3,3,3-PENTAAMINO-1λ5,3λ5-DIPHOSPHAZ-2-ENES, METHOD FOR PRODUCING THEM AND THEIR USE AS AGENTS FOR REGULATING OR INHIBITING ENZYMATIC HYDROLYSIS OF UREA
12/15/2005WO2005118601A2 Sulfonylethyl phosphorodiamidates for use in the treatment of cancer
12/15/2005WO2005118523A1 Amino-propanol derivatives
12/15/2005WO2005117908A2 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases
12/15/2005WO2005117907A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
12/15/2005WO2005117904A2 Phosphonate analogs of hiv integrase inhibitor compounds
12/15/2005WO2005100307A3 Methods of making an antistatic agent
12/15/2005WO2005095424A8 Preparation of p-chirogenic phospholanes and their use in asymetric synthesis
12/15/2005WO2005016252A3 Phosphorus-containing macrocycles
12/15/2005US20050277780 Vapor deposition of metal oxides, silicates and phosphates, and silicon dioxide
12/15/2005US20050277772 Monophosphine compound, transition metal complex thereof and production method of optically active compound using the complex as asymmetric catalyst
12/15/2005US20050277622 for treatment of viral infection, tumor, AIDS, fever, ache, and constipation, improvement of immunity, kidney function, neural regulation and physical recovery
12/15/2005US20050277620 Aryl phosphate derivatives of d4T
12/15/2005US20050277619 Preventing type II diabetes and treating impaired glucose tolerance, insulin resistance, hyperlipidemia, atherosclerosis, ischemic injury, and hypercholesterolemia by administering a purine containing a phosphonate group, e.g., N9-neopentyl-2-methylthio-8-(2-(5-phosphono)furanyl)adenine;